Harvard Bioscience, Inc. (HBIO) News
Filter HBIO News Items
HBIO News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest HBIO News From Around the Web
Below are the latest news stories about HARVARD BIOSCIENCE INC that investors may wish to consider to help them evaluate HBIO as an investment opportunity.
Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023HOLLISTON, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced it will be presenting at the Benchmark Company 12th Annual Discovery One-on-One Investor Conference to be held Thursday December 7th, 2023 at the New York Athletic Club in New York City. The conference offers emerging growth and dynamic publicly traded companies access to institutional and individual investors in a unique one-on-one format during which Jim Green, Chairman and Chief Executi |
With 60% ownership, Harvard Bioscience, Inc. (NASDAQ:HBIO) boasts of strong institutional backingKey Insights Significantly high institutional ownership implies Harvard Bioscience's stock price is sensitive to their... |
Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023HOLLISTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the Southwest IDEAS Investor Conference on Thursday November 16, 2023 at The Statler in Dallas, Texas. Joining him will be Jennifer Cote, the company’s Chief Financial Officer and Treasurer. The Company’s presentation will begin at 9:40 AM ET / 8:40 AM CT on November 16th. A replay of the presentation will be |
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2023 Earnings Call TranscriptHarvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2023 Earnings Call Transcript November 7, 2023 Harvard Bioscience, Inc. misses on earnings expectations. Reported EPS is $0.01 EPS, expectations were $0.04. Operator: Thank you for standing by and welcome to the Harvard Biosciences Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, today’s program is being recorded. […] |
Q3 2023 Harvard Bioscience Inc Earnings CallQ3 2023 Harvard Bioscience Inc Earnings Call |
Harvard Bioscience Inc (HBIO) Reports Q3 2023 Earnings: Gross Margin Expands Amid Revenue DeclineDespite a 6% revenue decline, the company's gross margin improved significantly year-over-year |
Harvard Bioscience Announces Third Quarter 2023 Financial ResultsQ3 Revenues of $25.4 millionQ3 Gross Margin of 58.1%Q3 GAAP operating loss of $0.9 million, adjusted operating income $1.8 millionContinued strong operating cash flow drove debt reduction of $8.3 million through Q3 HOLLISTON, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the third quarter ended September 30, 2023. Jim Green, Chairman and CEO said, “Overall, I’m encouraged to see solid year-over-year third qu |
Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023Innovative solutions for academic, CRO, pharma and biotech customersHOLLISTON, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that it will be showcasing its latest product innovations at the Society for Neuroscience (SfN) conference from November 12-15, 2023, in Washington, D.C. Complementing an already extensive product line, the new innovations provide exciting new opportunities for advancing preclinical and organoid-focused research and therap |
Harvard Bioscience Schedules Third Quarter 2023 Earnings Conference Call for November 7, 2023 at 8:00 AM ETHOLLISTON, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended September 30, 2023 before the market opens on November 7, 2023, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. Participants who would like to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number. Participants who would like to join the a |
Harvard Bioscience's (NASDAQ:HBIO) investors will be pleased with their respectable 77% return over the last yearIt hasn't been the best quarter for Harvard Bioscience, Inc. ( NASDAQ:HBIO ) shareholders, since the share price has... |